Colgate-Palmolive India has posted a net profit of Rs 165 m in 2QFY02. The company's sales growth declined marginally to Rs 2,930 m during the quarter. The slowdown seems to have affected Colgate's topline growth.
Net Sales (incl. Excise duty)
Operating Profit (EBDIT)
Operating Profit Margin (%)
Profit before Tax
Profit after Tax
Net profit margin (%)
Effective tax rate (%)
No. of Shares (eoy) (m)
Diluted earnings per share*
On first glance, Colgate's bottomline has declined by 6% YoY. However, Colgate had earned an extraordinary income in the previous year by sale of residential property. If we exclude this, the Colgate's bottomline has actually surged by 23%.
But Colgate has earned a huge dividend from its Nepal subsidiary, both in the first quarter and the second quarter of FY02. The total dividend earned in 1HFY02 amounts to around Rs 75 m. It is based on this that Colgate has seen a huge surge in other income both in first and second quarter of FY02.
If we therefore, only look at the operational performance, we realise that in the second quarter operating margins have slipped marginally and that too because of a sluggish topline. However, Colgate's inability to cut its advertising costs have really affected the company's profitability.
Raw material/packaging cost
If we look at the cost structure then Colgate has managed to keep its material costs under control. However, its staff cost has escalated and so has its advertising expense. Its Colgate's ad expenses that have been causing problems to the company's financials. Colgate's ad spend to sales ratio is the highest in the FMCG sector at 23% in 2QFY02. The company is caught in a fix wherein it has to spend more on advertising to keep its turf safe from HLL. However, this move does not seem to be paying off. With the economic slowdown as well as increasing competitive pressure from HLL, the company has faced pressure both on margins as well as the topline.
At the current price of Rs 162 the stock trades at a P/E of 34x annualised 1HFY02 earnings. The stock is likely to see weakness in the days to follow.
LEGAL DISCLAIMER: Equitymaster Agora Research Private Limited (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA or Canada, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.
Equitymaster Agora Research Private Limited. 103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India. Telephone: +91-22-61434055. Fax: +91-22-22028550. Email: email@example.com. Website: www.equitymaster.com. CIN:U74999MH2007PTC175407